1. Global Biomarkers Market - Market Overview

2. Executive Summary

3. Global Biomarkers Market - Market Landscape

3.1. Market Share Analysis

3.2. Comparative Analysis

3.2.1. Product Benchmarking

3.2.2. Patent Analysis

3.2.3. End user profiling

3.2.4. Top 5 Financials Analysis

4. Global Biomarkers Market- Market Forces

4.1. Market Drivers

4.2. Market Constraints

4.3. Market Challenges

4.4. Attractiveness of the Industry

4.4.1. Power of Suppliers

4.4.2. Power of Customers

4.4.3. Threat of New entrants

4.4.4. Threat of Substitution

4.4.5. Degree of Competition

5. Global Biomarkers Market - Strategic Analysis

5.1. Value Chain Analysis

5.2. Opportunities Analysis

5.3. Product lifecycle

5.4. Pricing Analysis

6. Global Biomarkers Market- By Types

6.1. Disease-related biomarkers

6.1.1. Diagnostic biomarker

6.1.2. Prognostic biomarker

6.2. Drug-related biomarkers

6.3. Imaging biomarkers

6.4. Molecular biomarkers

6.5. Surrogate biomarkers

6.6. Others

7. Global Biomarkers Market- By Application

7.1. Drug discovery & Development

7.2. Molecular diagnostics

7.3. Genetic studies

7.4. Clinical Trials

7.5. Bioinformatics

7.6. Others

8. Global Biomarkers Market- By Therapeutic areas

8.1. Oncology

8.2. Cardiology

8.3. Immunology

8.4. Neurology

8.5. Others

9. Global Biomarkers Market- By Products

9.1. Hormones

9.2. Enzymes

9.3. Antibodies

9.4. Gene products

9.5. Others

10. Global Biomarkers Market- By End Users

10.1. Pharmaceutical Companies

10.2. Hospitals

10.3. Research Institutes

10.4. CROs

10.5. Diagnostic Labs

11. Global Biomarkers Market -Geographic Analysis

11.1. North America

11.1.1. Canada

11.1.2. Mexico

11.1.3. USA

11.1.4. Others

11.2. Europe

11.2.1. France

11.2.2. Germany

11.2.3. Italy

11.2.4. Sweden

11.2.5. U.K

11.2.6. Others

11.3. APAC

11.3.1. China

11.3.2. India

11.3.3. Japan

11.3.4. Australia

11.3.5. Others

11.4. ROW

11.4.1. South Africa

11.4.2. South America

11.4.3. Russia

11.4.4. Saudi Arabia

11.4.5. Others

12. Market Entropy

12.1. New Product Launches

12.2. M&As, Collaborations, JVs and Partnerships

13. Company profiles

13.1. Qiagen N.V.

13.2. PerkinElmer, Inc.

13.3. Merck & Co, Inc.

13.4. Bio-Rad Laboratories

13.5. Enzo Biochem

13.6. EKF Diagnostics Holdings plc

13.7. Meso Scale Diagnostics, LLC

13.8. Singulex, Inc.

13.9. BioSims Technologies

13.10. Cisbio Bioassays

13.11. Signosis, Inc.

13.12. Roche Diagnostic Limited

13.13. Siemens Healthcare

13.14. Abbott Laboratories Inc.

13.15. Thermo Fisher Scientific, Inc.

13.16. Agilent Technologies Inc.

13.17. Aushon BioSystem Inc.

13.18. Epistem Ltd

13.19. G.E. Healthcare Inc.

13.20. Beckman Coulter, Inc.

13.21. Biomoda, Inc.

13.22. Epigenomics AGĀ 

"*Financials would be provided on a best efforts basis for private companies"

14. Appendix

14.1. Abbreviations

14.2. Sources

14.3. Research Methodology

14.4. Bibliography

14.5. Compilation of Expert Insights

14.6. Disclaimer